These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

168 related items for PubMed ID: 35503767

  • 21. Characterization of CD4/CD8+ αβ and Vγ2Vδ2+ T cells in HIV-negative individuals with different Mycobacterium tuberculosis infection statuses.
    Gao Y, Zhang S, Ou Q, Shen L, Wang S, Wu J, Weng X, Chen ZW, Zhang W, Shao L.
    Hum Immunol; 2015 Nov; 76(11):801-7. PubMed ID: 26429305
    [Abstract] [Full Text] [Related]

  • 22. Lack of Response to HBHA in HIV-Infected Patients with Latent Tuberculosis Infection.
    Delogu G, Vanini V, Cuzzi G, Chiacchio T, De Maio F, Battah B, Pinnetti C, Sampaolesi A, Antinori A, Goletti D.
    Scand J Immunol; 2016 Dec; 84(6):344-352. PubMed ID: 27636597
    [Abstract] [Full Text] [Related]

  • 23. Mycobacteria-Specific Mono- and Polyfunctional CD4+ T Cell Profiles in Children With Latent and Active Tuberculosis: A Prospective Proof-of-Concept Study.
    Tebruegge M, Ritz N, Donath S, Dutta B, Forbes B, Clifford V, Zufferey C, De Rose R, Robins-Browne RM, Hanekom W, Graham SM, Connell T, Curtis N.
    Front Immunol; 2019 Dec; 10():431. PubMed ID: 31024518
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Mycobacterium tuberculosis is less likely to acquire pathogenic mutations during latent infection than during active disease.
    Osugi A, Tamaru A, Yoshiyama T, Iwamoto T, Mitarai S, Murase Y.
    Microbiol Spectr; 2024 Jul 02; 12(7):e0428923. PubMed ID: 38786200
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Co-infection with Mycobacterium tuberculosis impairs HIV-Specific CD8+ and CD4+ T cell functionality.
    Chetty S, Govender P, Zupkosky J, Pillay M, Ghebremichael M, Moosa MY, Ndung'u T, Porichis F, Kasprowicz VO.
    PLoS One; 2015 Jul 02; 10(3):e0118654. PubMed ID: 25781898
    [Abstract] [Full Text] [Related]

  • 34. Patients with tuberculosis disease have Mycobacterium tuberculosis-specific CD8 T cells with a pro-apoptotic phenotype and impaired proliferative capacity, which is not restored following treatment.
    Day CL, Moshi ND, Abrahams DA, van Rooyen M, O'rie T, de Kock M, Hanekom WA.
    PLoS One; 2014 Jul 02; 9(4):e94949. PubMed ID: 24740417
    [Abstract] [Full Text] [Related]

  • 35. Rv2204c, Rv0753c and Rv0009 antigens specific T cell responses in latent and active TB - a flow cytometry-based analysis.
    Pathakumari B, Devasundaram S, Maddineni P, Raja A.
    Int J Med Microbiol; 2018 Mar 02; 308(2):297-305. PubMed ID: 29325881
    [Abstract] [Full Text] [Related]

  • 36. Treatment of latent tuberculosis infection induces changes in multifunctional Mycobacterium tuberculosis-specific CD4+ T cells.
    Sauzullo I, Mengoni F, Mascia C, Rossi R, Lichtner M, Vullo V, Mastroianni CM.
    Med Microbiol Immunol; 2016 Feb 02; 205(1):37-45. PubMed ID: 26108901
    [Abstract] [Full Text] [Related]

  • 37. Activation Phenotype of Mycobacterium tuberculosis-Specific CD4+ T Cells Promoting the Discrimination Between Active Tuberculosis and Latent Tuberculosis Infection.
    Luo Y, Xue Y, Mao L, Lin Q, Tang G, Song H, Liu W, Tong S, Hou H, Huang M, Ouyang R, Wang F, Sun Z.
    Front Immunol; 2021 Feb 02; 12():721013. PubMed ID: 34512645
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Study of CD27 and CCR4 Markers on Specific CD4+ T-Cells as Immune Tools for Active and Latent Tuberculosis Management.
    Latorre I, Fernández-Sanmartín MA, Muriel-Moreno B, Villar-Hernández R, Vila S, Souza-Galvão ML, Stojanovic Z, Jiménez-Fuentes MÁ, Centeno C, Ruiz-Manzano J, Millet JP, Molina-Pinargote I, González-Díaz YD, Lacoma A, Luque-Chacón L, Sabriá J, Prat C, Domínguez J.
    Front Immunol; 2018 Feb 02; 9():3094. PubMed ID: 30687314
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.